[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fWUSwpPtnJP4FZN184QmgOYIgPp_AfOV2wraqeiyJmts":3},{"answer":4,"createTime":5,"id":6,"options":7,"origin":12,"question":19,"related":20,"source":30,"type":31},[],"2025-12-26 01:39:37",286759772,[8,9,10,11],"仅受试者","受试者和监查员","受试者、研究者及数据分析人员","仅研究护士",{"count":13,"courseId":14,"courseImg":15,"courseName":16,"workId":17,"workName":18},25,"53e1d2ef4961cca8eea3e23969ad2cb9","https:\u002F\u002Ftihai-oss-cloud.itihey.com\u002Fimg\u002F03a579384a6dc297c89809b582fcc767.png","默认课程","work_46754089","试验方案测试","在一项双盲临床试验中,以下哪类人员应当不知道治疗分配信息",[21,32,35,44,53,62,71,80,89,98],{"answer":22,"createTime":5,"id":23,"options":24,"question":29,"source":30,"type":31},[],286759771,[25,26,27,28],"用于记录受试者知情同意过程的法律文件","指导参与试验的研究者如何启动和实施临床试验的文件","研究者与申办方签署的合作协议","统计人员进行数据分析时使用的参考手册","下列关于临床试验方案的描述,哪项最准确地反映了其定义","v1",0,{"answer":33,"createTime":5,"id":6,"options":34,"question":19,"source":30,"type":31},[],[8,9,10,11],{"answer":36,"createTime":5,"id":37,"options":38,"question":43,"source":30,"type":31},[],286759773,[39,40,41,42],"伦理学问题","监查员的联系方式","有效性评价","质量控制和质量保证","以下哪项不属于《药物临床试验质量管理规范》第六章规定的临床试验方案必须包含的15项内容之一",{"answer":45,"createTime":5,"id":46,"options":47,"question":52,"source":30,"type":31},[],286759774,[48,49,50,51],"入选标准","排除标准","脱落标准","剔除标准","某临床试验方案规定:年龄大于65岁或肌酐清除率低于30ml\u002Fmin的患者不得入组.这一规定属于哪种标准",{"answer":54,"createTime":5,"id":55,"options":56,"question":61,"source":30,"type":31},[],286759775,[57,58,59,60],"保证随机分配","防止选择性入组","维持盲态完整性","简化统计分析","在一项双盲安慰剂对照的降压药临床试验中,试验药与安慰剂在外观、剂型、服用方式上完全一致.这种设计主要是为了实现以下哪项要求",{"answer":63,"createTime":5,"id":64,"options":65,"question":70,"source":30,"type":31},[],286759776,[66,67,68,69],"增加样本量","统一培训并进行一致性评估","更换主要终点","减少研究中心数量","在多中心临床试验中,若发现主要疗效指标在不同中心之间存在较大变异,最合理的质量控制措施是",{"answer":72,"createTime":5,"id":73,"options":74,"question":79,"source":30,"type":31},[],286759777,[75,76,77,78],"给予错误的治疗或错误的药量","纳入不符合入排标准的受试者","访视超窗","药品保存超温","某受试者因实验室检查指标异常未被及时排除,最终入组并发生严重不良反应.该事件最符合以下哪种方案违背类型",{"answer":81,"createTime":5,"id":82,"options":83,"question":88,"source":30,"type":31},[],286759778,[84,85,86,87],"试验方案仅需说明试验目的和设计,不包括统计学考虑","试验方案是指导临床试验实施的重要文件,需在伦理委员会批准后执行","试验方案可以随时由研究者修改,无需再次提交伦理委员会","试验方案中不需要包括受试者的入选和排除标准","下列关于临床试验方案的描述哪项是正确的",{"answer":90,"createTime":5,"id":91,"options":92,"question":97,"source":30,"type":31},[],286759779,[93,94,95,96],"可以入组","不可以入组","由研究者决定是否入组","由申办者决定是否入组","在临床试验中,若某受试者符合所有入选标准但符合某条排除标准,是否可以入组",{"answer":99,"createTime":5,"id":100,"options":101,"question":106,"source":30,"type":31},[],286759780,[102,103,104,105],"试验目的与试验设计","受试者的入选与排除标准","知情同意书的具体内容","有效性与安全性评价方法","下列哪项不属于临床试验方案应包括的内容"]